MZEI

 
Common Stock SEC Reporting - Current
OTCQB
Contact Info
  • 4000 Bridgeway
  • Suite 401
  • Sausalito, CA 94965

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000753772
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 5122 - Drugs, proprietaries, and sundries
Incorporated In: NV, USA
Year of Inc. 1984
Employees 4 a/o Sep 24, 2014
Company Officers/Contacts
Edwin G. Marshall CEO
Stephanie Lynn Sorensen CFO
Jill Marshall Director, Ops.
Dr. Michael E. Shannon Medical Director, President
Company Directors
Vincent C Caponi Independent Director, Audit Committee Member, Compensation Committee Member
David A. Esposito Independent Director, Audit Committee Member, Compensation Committee Member
Daniel Hoyt Independent Director, Audit Committee Member, Compensation Committee Member
Edwin G. Marshall
Dr. Michael E. Shannon
Service Providers
Accounting/Auditing Firm
Tanner LLC
215 South State St.
Suite 800
Salt Lake City, UT, 84111
United States
 
Securities Counsel
Durham, Jones & Pinegar Law
111 East Broadway
Suite 900
Salt Lake City, UT, 84111
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Madison Funding, Inc. to 3-86
MZEI Security Details
Share Structure
Market Value1 $41,363,077 a/o Feb 17, 2017
Authorized Shares 395,000,000 a/o Sep 30, 2016
Outstanding Shares 393,934,068 a/o Nov 10, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 2,350 a/o Mar 03, 2016
Short Selling Data
Short Interest 747 (-89.74%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security